Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 24, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details a specific transaction on January 20, 2006:
- Abacus (GSK) Trustees Limited, acting as trustee for the GlaxoSmithKline Employee Trust ("GSK Trust"), transferred 14,296 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991.
- The Company was advised of these transactions on January 23, 2006.
Management Commentary and Risks
The GSK Trust is identified as a discretionary trust where all current and former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. The filing notes that three directors—Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop—hold an interest in the shares held within the GSK Trust in the same capacity as other employees. No other risks, contingencies, or unusual items are disclosed in this text.
Investor Verification Checklist
- Verify the total number of shares transferred (14,296) and the specific plan involved (SmithKline Beecham Employee Share Option Plan 1991).
- Confirm the date of the transaction (January 20, 2006) versus the date of company notification (January 23, 2006).
- Review the status of the three named directors (Dr J-P Garnier, Dr T Yamada, Mr J S Heslop) regarding their interest in the GSK Trust.
- Note that this filing contains no financial performance data; refer to Form 20-F for fiscal results.